Order Total (1 Item Items):
Shipping Destination:
Felli James (29 results)
Skip to main search results
Search filters
Product Type
- All Product Types
- Books (29)
- Magazines & Periodicals (No further results match this refinement)
- Comics (No further results match this refinement)
- Sheet Music (No further results match this refinement)
- Art, Prints & Posters (No further results match this refinement)
- Photographs (No further results match this refinement)
- Maps (No further results match this refinement)
- Manuscripts & Paper Collectibles (No further results match this refinement)
Condition Learn more
- New (22)
- As New, Fine or Near Fine (5)
- Very Good or Good (2)
- Fair or Poor (No further results match this refinement)
- As Described (No further results match this refinement)
Binding
Collectible Attributes
- First Edition (No further results match this refinement)
- Signed (No further results match this refinement)
- Dust Jacket (No further results match this refinement)
- Seller-Supplied Images (8)
- Not Print on Demand (25)
Language (1)
Price
- Any Price
- Under US$ 25 (No further results match this refinement)
- US$ 25 to US$ 50
- Over US$ 50
Free Shipping
Seller Location
Seller Rating
-
Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)
Book 40 of 151: Chapman & Hall/CRC BiostatisticsLanguage: English
Published by Chapman and Hall/CRC Press, 2013
ISBN 10: 1439867941 ISBN 13: 9781439867945
Condition: Very Good. Very Good++; Hardcover; Close to new condition; Covers are still glossy with "straight" edge-corners; Unblemished textblock edges; The endpapers and all text pages are bright and unmarked; Binding is tight with a straight spine; This book will be stored and delivered in a sturdy cardboard box with foam padding; Medium Format (8.5" - 9.75" tall); Dark blue and aqua covers with title in white lettering; 2013, Chapman and Hall/CRC Press; 220 pages; "Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)," by Andreas Sashegyi, et al.
-
Benefit-risk Assessment in Pharmaceutical Research and Development
Book 42 of 151: Chapman & Hall/CRC BiostatisticsLanguage: English
Published by Chapman and Hall/CRC, 2020
ISBN 10: 0367576244 ISBN 13: 9780367576240
Condition: As New. Unread book in perfect condition.
-
Benefit-Risk Assessment in Pharmaceutical Research and Development
Book 42 of 151: Chapman & Hall/CRC BiostatisticsLanguage: English
Published by Chapman and Hall/CRC, 2020
ISBN 10: 0367576244 ISBN 13: 9780367576240
Condition: New. pp. 220.
-
Benefit-risk Assessment in Pharmaceutical Research and Development
Book 42 of 151: Chapman & Hall/CRC BiostatisticsLanguage: English
Published by Chapman and Hall/CRC, 2020
ISBN 10: 0367576244 ISBN 13: 9780367576240
Condition: New.
-
Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)
Book 40 of 151: Chapman & Hall/CRC BiostatisticsLanguage: English
Published by Chapman and Hall/CRC, 2013
ISBN 10: 1439867941 ISBN 13: 9781439867945
Hardcover. Condition: Very Good. 1439867941 Very Good++; Hardcover; Close to new condition; Covers are still glossy with "straight" edge-corners; Unblemished textblock edges; The endpapers and all text pages are bright and unmarked; Binding is tight with a straight spine; This book will be stored and delivered in a sturdy cardboard box with foam padding; Medium Format (8.5" - 9.75" tall); Aqua and blue covers with title in white lettering; 2013, Chapman and Hall/CRC; 220 pages; "Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)," by Andreas Sashegyi, et al.
-
Benefit-Risk Assessment in Pharmaceutical Research and Development
Book 40 of 151: Chapman & Hall/CRC BiostatisticsLanguage: English
Published by Chapman and Hall/CRC, 2020
ISBN 10: 0367576244 ISBN 13: 9780367576240
Condition: New. pp. 220.
-
Benefit-risk Assessment in Pharmaceutical Research and Development
Book 42 of 151: Chapman & Hall/CRC BiostatisticsLanguage: English
Published by Chapman and Hall/CRC, 2020
ISBN 10: 0367576244 ISBN 13: 9780367576240
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Seller rating 5 out of 5 stars
US$ 77.07
US$ 20.22 shipping
Ships from United Kingdom to U.S.A.Quantity: 1 available
Add to basketCondition: As New. Unread book in perfect condition.
-
Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)
Book 40 of 151: Chapman & Hall/CRC BiostatisticsLanguage: English
Published by Chapman and Hall/CRC, 2013
ISBN 10: 1439867941 ISBN 13: 9781439867945
hardcover. Condition: New. Brand New Book.
-
Benefit-Risk Assessment in Pharmaceutical Research and Development
Book 42 of 151: Chapman & Hall/CRC BiostatisticsLanguage: English
Published by Taylor & Francis Ltd, 2020
ISBN 10: 0367576244 ISBN 13: 9780367576240
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
Seller rating 5 out of 5 stars
US$ 80.67
US$ 19.99 shipping
Ships from United Kingdom to U.S.A.Quantity: 1 available
Add to basketPaperback / softback. Condition: New. New copy - Usually dispatched within 4 working days.
-
Benefit-risk Assessment in Pharmaceutical Research and Development
Book 42 of 151: Chapman & Hall/CRC BiostatisticsLanguage: English
Published by Chapman and Hall/CRC, 2020
ISBN 10: 0367576244 ISBN 13: 9780367576240
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Seller rating 5 out of 5 stars
US$ 80.66
US$ 20.22 shipping
Ships from United Kingdom to U.S.A.Quantity: 1 available
Add to basketCondition: New.
-
Benefit-Risk Assessment in Pharmaceutical Research and Development
Book 40 of 151: Chapman & Hall/CRC BiostatisticsLanguage: English
Published by Chapman and Hall/CRC, 2020
ISBN 10: 0367576244 ISBN 13: 9780367576240
Condition: New. pp. 220.
-
Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)
Book 42 of 151: Chapman & Hall/CRC BiostatisticsLanguage: English
Published by Chapman and Hall/CRC, 2020
ISBN 10: 0367576244 ISBN 13: 9780367576240
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
US$ 87.48
US$ 16.15 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. In.
-
Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics)
Book 40 of 151: Chapman & Hall/CRC BiostatisticsLanguage: English
Published by Taylor & Francis Inc, 2013
ISBN 10: 1439867941 ISBN 13: 9781439867945
hardcover. Condition: Sehr gut. 220 Seiten; 9781439867945.2 Gewicht in Gramm: 1.
-
Benefit-risk Assessment in Pharmaceutical Research and Development
Book 40 of 151: Chapman & Hall/CRC BiostatisticsUS$ 110.74
US$ 13.48 shipping
Ships from United Kingdom to U.S.A.Quantity: 2 available
Add to basketPaperback. Condition: Brand New. 220 pages. 9.25x6.14x0.51 inches. In Stock.
-
-
Benefit-Risk Assessment in Pharmaceutical Research and Development
Book 40 of 151: Chapman & Hall/CRC BiostatisticsLanguage: English
Published by Chapman and Hall/CRC, 2013
ISBN 10: 1439867941 ISBN 13: 9781439867945
Condition: As New. Unread book in perfect condition.
-
Benefit-Risk Assessment in Pharmaceutical Research and Development
Book 40 of 151: Chapman & Hall/CRC BiostatisticsLanguage: English
Published by Chapman and Hall/CRC, 2013
ISBN 10: 1439867941 ISBN 13: 9781439867945
Condition: New.
-
Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)
Book 42 of 151: Chapman & Hall/CRC BiostatisticsLanguage: English
Published by Chapman and Hall/CRC, 2020
ISBN 10: 0367576244 ISBN 13: 9780367576240
US$ 119.42
US$ 33.70 shipping
Ships from United Kingdom to U.S.A.Quantity: 1 available
Add to basketpaperback. Condition: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
-
Benefit-Risk Assessment in Pharmaceutical Research and Development
Book 40 of 151: Chapman & Hall/CRC BiostatisticsLanguage: English
Published by Chapman and Hall/CRC, 2013
ISBN 10: 1439867941 ISBN 13: 9781439867945
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Seller rating 5 out of 5 stars
US$ 139.40
US$ 20.22 shipping
Ships from United Kingdom to U.S.A.Quantity: 10 available
Add to basketCondition: New.
-
Benefit-Risk Assessment in Pharmaceutical Research and Development
Book 40 of 151: Chapman & Hall/CRC BiostatisticsLanguage: English
Published by Chapman and Hall/CRC, 2013
ISBN 10: 1439867941 ISBN 13: 9781439867945
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Seller rating 5 out of 5 stars
US$ 139.28
US$ 20.22 shipping
Ships from United Kingdom to U.S.A.Quantity: 10 available
Add to basketCondition: As New. Unread book in perfect condition.
-
Benefit-Risk Assessment in Pharmaceutical Research and Development
Book 40 of 151: Chapman & Hall/CRC BiostatisticsLanguage: English
Published by Taylor & Francis Inc, 2013
ISBN 10: 1439867941 ISBN 13: 9781439867945
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
Seller rating 5 out of 5 stars
US$ 145.66
US$ 21.04 shipping
Ships from United Kingdom to U.S.A.Quantity: 1 available
Add to basketHardback. Condition: New. New copy - Usually dispatched within 4 working days.
-
Benefit Risk Analysis in Pharmaceutical Research and Development
Book 42 of 151: Chapman & Hall/CRC BiostatisticsLanguage: English
Published by Taylor & Francis Group, 2013
ISBN 10: 1439867941 ISBN 13: 9781439867945
Condition: New. pp. 220.
-
Benefit Risk Analysis in Pharmaceutical Research and Development
Book 42 of 151: Chapman & Hall/CRC BiostatisticsLanguage: English
Published by Taylor & Francis Group, 2013
ISBN 10: 1439867941 ISBN 13: 9781439867945
Condition: New. pp. 220.
-
Benefit-Risk Assessment in Pharmaceutical Research and Devel
Book 40 of 151: Chapman & Hall/CRC BiostatisticsUS$ 142.12
US$ 57.04 shipping
Ships from Germany to U.S.A.Quantity: Over 20 available
Add to basketGebunden. Condition: New.
-
Benefit-Risk Assessment in Pharmaceutical Research and Development
Book 40 of 151: Chapman & Hall/CRC BiostatisticsLanguage: English
Published by Taylor & Francis Inc Nov 2013, 2013
ISBN 10: 1439867941 ISBN 13: 9781439867945
Buch. Condition: Neu. Neuware - Many practitioners in the pharmaceutical industry are still largely unfamiliar with benefit-risk assessment, despite its growing prominence in drug development and commercialization. Helping to alleviate this knowledge gap, Benefit-Risk Assessment in Pharmaceutical Research and Development provides a succinct overview of the key considerations relevant to benefit-risk assessment across the pharmaceutical R&D spectrum, from early clinical development to late-stage development to regulatory review to post-launch assessment. The book first presents interpretations of benefit and risk in the context of a molecule moving from preclinical evaluation into its early testing in humans. It next considers benefit and risk characterization and assessment during a molecule's journey from its clinical evaluation in humans through its submission to regulators for marketing approval. Throughout these sections, the book offers insight into the role of benefit-risk assessment in heightening understanding among key stakeholders by shaping questions and guiding discussions among scientists, physicians, developers, and regulatory agencies.The book also focuses on a molecule's entry into the marketplace as a drug available for consumption by people. It explores the role of benefit-risk assessment as the relevance of carefully collected clinical efficacy and safety metrics fades in the wake of real-world use and evidence of effectiveness and safety. Bringing together the expertise of 15 contributors from academia and the industry, this book offers an easy-to-read guide to the various facets of benefit-risk assessment in the major stages of pharmaceutical R&D. Suitable for those in both technical and managerial roles, it enables readers to communicate more effectively across their development chain as well as rationally and thoughtfully embed benefit-risk assessment into their R&D processes.
-
PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
-
Benefit-Risk Assessment in Pharmaceutical Research and Development
Book 42 of 151: Chapman & Hall/CRC BiostatisticsSeller: PBShop.store UK, Fairford, GLOS, United Kingdom
Seller rating 5 out of 5 stars
US$ 88.87
US$ 6.77 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketPAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
-
Benefit Risk Analysis in Pharmaceutical Research and Development
Book 40 of 151: Chapman & Hall/CRC BiostatisticsLanguage: English
Published by Taylor & Francis Group, 2013
ISBN 10: 1439867941 ISBN 13: 9781439867945
US$ 141.51
US$ 8.76 shipping
Ships from United Kingdom to U.S.A.Quantity: 3 available
Add to basketCondition: New. pp. 220 A 7 fig, 4-page color insert will appear of Figs. 5.10-5.16. follows page 96 This item is printed on demand.
-
Benefit-Risk Assessment in Pharmaceutical Research and Development
Book 42 of 151: Chapman & Hall/CRC BiostatisticsLanguage: English
Published by Chapman And Hall/CRC, 2020
ISBN 10: 0367576244 ISBN 13: 9780367576240
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Bringing together the expertise of 15 contributors from academia and the industry, this book offers an easy-to-read guide to the various facets of benefit-risk assessment in the major stages of pharmaceutical R&D, from early clinical development to late-stage development to regulatory review to post-launch assessment. Suitable for those in b.
